Autoantibodies against type I IFNs in patients with life-threatening COVID-19
2020 · Science · 2,815 citations
https://doi.org/10.1126/science.abd4585
M
Marina Elena Cazzaniga
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
319
Papers
14.1K
Citations
46
h-index
122
i10-index
Marina Elena Cazzaniga is an academic researcher from Azienda Ospedaliera San Gerardo. The author has contributed to research in topics: Cancer Treatment and Pharmacology & Advanced Breast Cancer Therapies & Breast Cancer Treatment Studies. The author has an h-index of 46, co-authored 272 publications.
ORCID: 0000-0003-1756-6935Papers by this author
worksInborn errors of type I IFN immunity in patients with life-threatening COVID-19
2020 · Science · 2,377 citations
https://doi.org/10.1126/science.abd4570
Mapping the human genetic architecture of COVID-19
2021 · Nature · 1,104 citations
https://doi.org/10.1038/s41586-021-03767-x
Elacestrant (oral selective estrogen receptor degrader) Versus Standard Endocrine Therapy for Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: Results From the Randomized Phase III EMERALD Trial
2022 · Journal of Clinical Oncology · 643 citations
https://doi.org/10.1200/jco.22.00338
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial
2020 · Journal of Translational Medicine · 111 citations
https://doi.org/10.1186/s12967-020-02573-9
A second update on mapping the human genetic architecture of COVID-19
2023 · Nature · 107 citations
https://doi.org/10.1038/s41586-023-06355-3
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat